Veterinary Medicines

THERIOS 75 MG CHEWABLE TABLETS FOR CATS

Authorised
  • Cefalexin monohydrate
Download as PDF

Product identification

Medicine name:
THERIOS 75 MG CHEWABLE TABLETS FOR CATS
Therios 75 mg purutabletti
Active substance:
  • Cefalexin monohydrate
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin monohydrate
    78.90
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • Cardboard box with 1 blister (Polyvinylchloride / thermo-elast / polyvinylidene chloride – aluminium heat-sealed) of 10 tablets
  • Cardboard box with 20 blisters (Polyvinylchloride / thermo-elast / polyvinylidene chloride – aluminium heat-sealed) of 10 tablets
  • Cardboard box with 15 blisters (Polyvinylchloride / thermo-elast / polyvinylidene chloride – aluminium heat-sealed)of 10 tablets
  • Cardboard box with 10 blisters (Polyvinylchloride / thermo-elast / polyvinylidene chloride – aluminium heat-sealed)of 10 tablets
  • Cardboard box with 2 blisters (Polyvinylchloride / thermo-elast / polyvinylidene chloride – aluminium heat-sealed) of 10 tablets
  • Cardboard box with 1 blister (Polyamide / aluminium / polyvinylchloride – aluminium heat-sealed) of 10 tablets
  • Cardboard box with 2 blisters (Polyamide / aluminium / polyvinylchloride – aluminium heat-sealed) of 10 tablets
  • Cardboard box with 10 blisters(Polyamide / aluminium / polyvinylchloride – aluminium heat-sealed) of 10 tablets
  • Cardboard box with 15 blisters (Polyamide / aluminium / polyvinylchloride – aluminium heat-sealed) of 10 tablets
  • Cardboard box with 20 blisters (Polyamide / aluminium / polyvinylchloride – aluminium heat-sealed) of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • CEVA Santé Animale
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 27742
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0213/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Romania
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 8/09/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 8/09/2025
Download